Time: 16:00 GMT

Opportunities to optimize manufacturing system performance can be found through cell culture supplementation. Specifically in animal-free cell culture supplements. InVitria, a company specializing in cell culture media supplements, is leading the way in animal-free supplements.

InVitria conducted several experiments with Matt Croughan at Keck Graduate Institute. Here are the findings:
- The benefits of animal-free supplements have been proven in small scale for research & development as well as mass production with bioreactors
- The use of cell culture supplements in increasing overall performance in manufacturing systems has shown to be beneficial for both performance and consistency

Key learnings:
• Cell Culture Strategies in Optimization of Overall Manufacturing Performance
• Effects of Cell Culture Supplements Relative to Productivity
• Animal-Free Supplement Benefits

The speaker: Steve Pettit - Director, Cell Culture Development, InVitria. Steve has over 20 years of cell culture and virology experience.

Additional Speaker: Brittany Medbery - Marketing Coordinator, InVitria

This is a must attend webinar for Managers, Supervisors, and R&D in the biopharmaceutical formulation and manufacturing, bioprocessing, stem cell and regenerative medicine, medical devices and diagnostics, and those involved in life sciences research.

Technical Requirements
- PC headset
- PC speakers
- Broadband Connection

The best manufacturing companies follow "key steps" that set them apart from the typical solid dosage manufacturing company.

- Learn what techniques they consider to be the "best" and how to implement them

- Discover ‘the seven keys’ to becoming a cost-effective solid dosage manufacturer with a competitive advantage

- Get the tools to implement a fully integrated learning system that will combine SOP's, batch records, theory, and actual employee function

Key elements that make solid dosage manufactures more competitive and efficient while achieving and maintaining the highest product quality possible:
• Understanding and following SOP's
• Employing a GMP mentality
• Maintaining equipment function
• Managing the supply chain
• Environmental controls to maintain forward motion

Each successful team must:
• Expect problems and know how to react
• Have clearly defined and effective procedures
• Consistently educate everyone, with clear repeatable objectives
• Ensure team members have the right tools & guidelines to help everyone do a better job

This is a must attend webinar for Managers, Supervisors, and those of you involved in the production of tablets & capsules, R&D, Technical Services, Engineering, Quality Assurance, Quality Control, or Purchasing.

Technical Requirements
- PC headset
- PC speakers
- Broadband Connection

The seminar will present the biotech and pharmaceutical sector in Spain and the investment opportunities that it offers.

The participants to this seminar will find answers to the following questions:

- Did you know that Spain is in the 4th position in Europe in scientific output in Biotechnology?

- Did you know that in Spain you will find one of the most widely admired life science networks, combining hospitals, research centres and an excellent healthcare system?

- Did you know that the number of new biotech companies in Spain increased by 166% from 2000 to 2006?

- Did you know that Spain has one of the most favourable financial environments and that in 2006 public financing reached 1 billion €?

- Did you know that the biotech sector in Spain employs around 88,100 people?

- Did you know that Spain is highly competitive at a global level in Advanced Therapies?

- Did you know that Cellerix is the first Spanish company with two orphan drugs approved by EMEA?

Confusion around the intended application of PhRMA guidelines and lack of awareness of insurance implications for clinical trial participants are unnecessarily handicapping clinical trial enrollment. Reactions to recent PhRMA guidelines have caused some sponsors to overly limit tactics for motivating and retaining both sites and trial participants. By doing so, sponsors are further decreasing sites’ abilities to maintain participants’ engagement in trials, and may be limiting site performance. Likewise, a lack of strategic planning around the implication of insurance coverage for study participants is directly affecting the likelihood that otherwise interested patients will participate in clinical trials.

This Webinar will address these two important issues and share best practices optimizing participant enrollment and site engagement within applicable guidelines.